6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Recommendations for control and prevention of human immunodeficiency virus (HIV) infection in intravenous drug users.

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Considerable evidence indicates that intravenous drug users are emerging as the group at greatest risk for both acquiring and spreading human immunodeficiency virus (HIV) infection. Thus, all possible methods to control the spread of HIV infection in intravenous drug users should be explored. Key recommendations are that HIV antibody testing of intravenous drug users should be voluntary, because mandatory testing is counterproductive; free distribution of needles and syringes to intravenous drug users should occur only in carefully controlled circumstances to determine its effectiveness in decreasing infection rates; and drug-free and methadone maintenance treatment programs should be available on demand to all intravenous drug users as a means of reducing the spread of HIV infection. At present, the primary strategy for prevention must be education resulting in behavioral change. Education is currently the only definitive means for controlling the spread of HIV infection among intravenous drug users, their sex contacts, and to fetuses.

          Related collections

          Author and article information

          Journal
          Ann. Intern. Med.
          Annals of internal medicine
          0003-4819
          0003-4819
          May 15 1989
          : 110
          : 10
          Affiliations
          [1 ] Department of Community Medicine, St. Vincent's Hospital and Medical Center, New York, NY 10011.
          Article
          2653157
          0d21035b-4549-4782-9c62-dea7ea3ab445

          Comments

          Comment on this article